Hemics Company

Hemics is a medical device company active in the field of Rheumatoid Arthritis (RA). We aim at improving the quality of life of patients with RA by creating imaging devices that support the rheumatologist in monitoring and treatment of this disease. Its devices are based on the patented Optical Inflammation Detection technology, a non-invasive, fast and objective method that supports rheumatologists in the quantification of inflammation, a key parameter in the treatment of patients with RA. Hemics was founded as a spin-out of Royal Philips Electronics, where the Optical Inflammation Detection technology was invented.

Founded Date: 2011-01-01
Investor Type: For Profit
Employee Number: 1-10
Funding Status: Early Stage Venture
Technology: Precision Medicine
Industry: P4 Medicine
Headquarters: Europe